Zobrazeno 1 - 10
of 14
pro vyhledávání: '"G C, Nicholson"'
Autor:
D. H. Gutteridge, G. O. Stewart, R. L. Prince, R. I. Price, R. W. Retallack, S. S. Dhaliwal, B. G. A. Stuckey, P. Drury, C. E. Jones, D. L. Faulkner, G. N. Kent, C. I. Bhagat, G. C. Nicholson, K. Jamrozik†
Publikováno v:
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 13(2)
Postmenopausal Caucasian women aged less than 80 years (n = 99) with one or more atraumatic vertebral fracture and no hip fractures, were treated by cyclical administration of enteric coated sodium fluoride (NaF) or no NaF for 27 months, with precaut
Publikováno v:
The Journal of clinical endocrinology and metabolism. 86(5)
Both serum leptin and bone mineral density are positively correlated with body fat, generating the hypothesis that leptin may be a systemic and/or local regulator of bone mass. We investigated 214 healthy, nonobese Australian women aged 20-91 yr. Bon
Publikováno v:
Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry. 4(4)
Fracture risk is determined by bone mineral density (BMD). The T-score, a measure of fracture risk, is the position of an individual's BMD in relation to a reference range. The aim of this study was to determine the magnitude of change in the T-score
Autor:
G C, Nicholson, M, Malakellis, F M, Collier, P U, Cameron, W R, Holloway, T J, Gough, C, Gregorio-King, M A, Kirkland, D E, Myers
Publikováno v:
Clinical science (London, England : 1979). 99(2)
Osteoclasts are bone-resorbing cells that are derived from haemopoietic precursors, including cells present in peripheral blood. The recent identification of RANKL [receptor activator of nuclear factor (NF)-kappaB ligand], a new member of the tumour
Publikováno v:
Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry. 3(3)
To evaluate the prevalence of osteoporosis at various sites among Australian women, cross-sectional bone mineral density (BMD) data for adult females was obtained from an age-stratified population-based sample (n = 1494; 20-94 yr) drawn at random fro
Publikováno v:
Journal of cellular physiology. 179(2)
c-Fos, a component of the dimeric transcription factor AP-1, is necessary for osteoclast formation. To determine whether c-Fos can substitute for any or all of the stimuli needed for osteoclast induction, we infected osteoclast precursors with retrov
Autor:
D N, O'Neal, R C, O'Brien, K L, Timmins, G D, Grieve, K P, Lau, G C, Nicholson, M A, Kotowicz, J D, Best
Publikováno v:
Diabetic medicine : a journal of the British Diabetic Association. 15(10)
The aim of this study was to determine the effect of the lipid modifying agent gemfibrozil on lipid and coagulation risk factors in patients with Type 2 diabetes mellitus (Type 2 DM). Twenty-six subjects with Type 2 DM and dyslipidaemia were treated
Publikováno v:
The Histochemical journal. 30(4)
Osteoclasts resorb bone by a complex dynamic process that initially involves attachment, polarization and enzyme secretion, followed by their detachment and migration to new sites. In this study, we postulated that mineralized and osteoid bone matrix
Autor:
F M, Collier, W H, Huang, W R, Holloway, J M, Hodge, M T, Gillespie, L L, Daniels, M H, Zheng, G C, Nicholson
Publikováno v:
Endocrinology. 139(3)
Although estrogen is important in human skeletal homeostasis, the major target cell in bone is unknown. Estrogen receptors (ER) have been demonstrated in osteoblasts and bone marrow stromal cells, but their presence in osteoclasts remains controversi
Autor:
A J, Fenton, B E, Kemp, R G, Hammonds, K, Mitchelhill, J M, Moseley, T J, Martin, G C, Nicholson
Publikováno v:
Endocrinology. 129(6)
We have recently shown that a carboxyl-terminal sequence of parathyroid hormone-related protein, PTHrP[107-139], is a potent direct inhibitor of osteoclastic bone resorption. We now report that this bone resorption inhibitory activity, which we have